Oncogenic KRAS-associated gene signature defines co-targeting of CDK4/6 and MEK as a viable therapeutic strategy in colorectal cancer - Concepedia

Concepedia

Publication | Closed Access

Oncogenic KRAS-associated gene signature defines co-targeting of CDK4/6 and MEK as a viable therapeutic strategy in colorectal cancer

87

Citations

30

References

2017

Year

Michelle Pek, Siti Maryam J. M. Yatim, Yongjiu Chen, Jun Li, Min Gong, Xia Jiang, Fan Zhang, Jianghua Zheng, Xiaojian Wu, Qiang Yu

OncologyViable Therapeutic StrategyMedicineColorectal CancerCell BiologyTumor SuppressorCancer GeneticsCancer BiologyRadiation OncologyTumor Biology

References

	Year	Citations

Page 1

Page 1